Nunn Jason Raleigh
- SEC CIK
- 0001444319
In the past year, 1 open-market purchase filing worth $1.20M and no sales.
Current role at each company
- ADXN Addex Therapeutics Ltd.Directoras of Sep 4, 2026
- ZBIO Zenas BioPharma, Inc.Directoras of Jun 17, 2026
- RGLS Regulus Therapeutics Inc.Directoras of Jun 27, 2025
- TRVN Trevena IncDirectoras of Jun 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.20M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$1.20M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Nunn Jason Raleigh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZBIO Zenas BioPharma, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 (view filing) | Oct 9 | 5 days | Nunn Jason RaleighDirector | PPurchase | +63.2K | $19.00 | +$1.20M | +5.7%1.17M after | |
| Sep 16, 2024 (view filing) | Sep 16 | Same day | Nunn Jason RaleighDirector | PPurchase | +882.4K | $17.00 | +$15.0M | +387.2%1.11M after | 2 lots |